FDA Investigator: Rajabi Abhari, Mohsen
- Rajabi Abhari, Mohsen first started conducting FDA inspections in 2016, with the last inspection in 2020. Over that time, Rajabi Abhari, Mohsen has conducted 32 inspections at 30 companies across 31 sites.
Get Rajabi Abhari, Mohsen's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 QPS Netherlands B.V., Groningen | 2019
Out-of-stock
Rajabi Abhari, Mohsen
Human Drug Form 483
FDA 483 Melbourn Scientific Limited, Royston | 2019
Out-of-stock
Rajabi Abhari, Mohsen
Human Drug Form 483
FDA 483 PPD Development, LLC, Middleton | 2018
Out-of-stock
Rajabi Abhari, Mohsen
Human Drug Form 483
Co-Investigators (16)
- Mohsen Rajabi Abhari, FDA Investigator
- Himanshu Gupta, FDA Investigator
- Sripal R. Mada, FDA Investigator
- Xikui Chen, FDA Investigator
- Gopa Biswas, FDA Investigator
- Makini Cobourne-Duval, FDA Investigator
- Hasan A. Irier, FDA Investigator
- Li-Hong P. Yeh, FDA Investigator
- Li-Hong Yeh, FDA Investigator
- Jonathan R. Campos, FDA Investigator
- Arindam Dasgupta, FDA Investigator
- Gajendiran Mahadevan, FDA Investigator
- Yiyue Zhang, FDA Investigator
- Lakecha N. Lewis, FDA Investigator
- Nicola M. Fenty-Stewart, FDA Investigator
- Xiaohan Cai, FDA Investigator